Journey Medical Corp (DERM) stock
Close on Nov 11, 2026Market cap $125.32MP/E –Yield –
Journey Medical Corp grew revenue 20.9% to $68.18M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $125.32M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $125.32M
- P/E ratio
- –
- Price to sales
- 1.84
- Price to book
- 3.90
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $68.18M
- Net income
- -$6.10M
- EPS, diluted
- -$0.23
- Book value per share
- $1.17
- Diluted shares
- 27M
Trading
- Next earnings
- Nov 11, 2026 (estimated, after the close)
- Previous close
- $4.42
- Open
- $4.43
- Day's range
- $4.38 – $4.56
- Volume
- 173,060
- Average volume (20 days)
- 187,041
- Beta (5 years)
- 0.69
- 52-week range
- $4.25 – $9.55
- RSI (14 days)
- 34.9
- Volatility (1 year)
- 67.5%
- Relative volume
- 0.93×
- WACC
- 8.8%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | DERM | S&P 500 | Difference | DERM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -29.6% | -2.4% | −27.2 pts | ||
| 3 months | -29.7% | -1.2% | −28.6 pts | ||
| Year to date | -42.4% | +12.3% | −54.7 pts | ||
| 1 year | -50.9% | +12.4% | −63.4 pts | ||
| 3 years | +19.0% | +78.8% | −59.8 pts | +6.0% | +21.4% |
| 5 years | -76.3% | +75.2% | −151.5 pts | -25.0% | +11.9% |
| 10 years | -87.4% | +311.1% | −398.5 pts | -18.7% | +15.2% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Journey Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Results
About Journey Medical
Pharmaceutical Preparations
Journey Medical Corporation is a commercial-stage pharmaceutical company that acquires, develops, and commercializes prescription pharmaceutical treatments for dermatological conditions. The company markets a portfolio of prescription products targeting diseases such as rosacea, severe acne, primary axillary hyperhidrosis, fungal skin infections, and wound care, with major brands including Emrosi, Qbrexza, Accutane, Amzeeq, and Zilxi. Its primary customers are specialty pharmacies, independent wholesalers, and distributors, which subsequently supply medications to retail pharmacy chains, independent pharmacies, and managed care organizations.
Company profile, executives and historyJourney Medical stock: common questions
What is Journey Medical's stock price?
DERM closed at $4.44 on Nov 11, 2026, up 0.45% on the day. Over the past 52 weeks it traded between $4.25 and $9.55.
What is Journey Medical's market cap?
Journey Medical was worth $125.32M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is DERM's P/E ratio?
Journey Medical lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.23), so it has no meaningful P/E ratio.
How much revenue does Journey Medical make?
Journey Medical reported revenue of $68.18M for the twelve months to Jun 30, 2026, up 20.9% from a year earlier.
Does Journey Medical pay a dividend?
No. Journey Medical has not paid a cash dividend over the last twelve months.
When does Journey Medical report earnings next?
Journey Medical is expected to report Q3 FY2026 results on Nov 11, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has DERM stock performed over the past year?
Including dividends, DERM returned -50.9% over the past year, against +12.4% for the S&P 500.
How many DERM shares are sold short?
3M shares were sold short at the latest FINRA report, 12.91% of the float, or 15.1 days of average trading volume.
Who are Journey Medical's competitors?
Companies most similar to Journey Medical by business, industry and size include FBIO, BFRI, AYTU, VRCA, RMTI.
See a number that looks wrong?